Good morning. I am Douglas Love, President and CEO of Annexon. I'm very happy to welcome you to Annexon's 2022 Annual Meeting of Shareholders. 2021 was a year of marked progress across our pipeline, which is designed to treat complement mediated disorders of the body, brain, and eye. We generated positive data with our lead drug candidate, ANX005, in Guillain-Barré syndrome and Huntington's disease, and continued to advance our pipeline of five fit-for-purpose drug candidates. Earlier this week, we announced promising final data from our phase ll trial of ANX005 in patients with Huntington's disease that support the continued development of ANX005 for that indication. As we look ahead, we are preparing for numerous clinical data readouts and new study initiations anticipated over the course of 2022 and 2023. This is an exciting time for Annexon. I am confident in our potential to deliver game-changing medicines to patients in need. We are conducting our annual meeting virtually via live audio webcast. Before I call the meeting to order, I'd like to introduce to you the members of the board and the business team who are present online with us today. The other members of the board participating online today are William H. Carson, Jung E. Choi, Bettina M. Cockroft, Muneer Satter, William Waddill, and Thomas G. Wiggans, our board chair. Other members of the company leadership team joining us online today are Jennifer Lew, Executive Vice President, Chief Financial Officer, and Corporate Secretary, Dr. Larry Mattheakis, Executive Vice President and Chief Scientific Officer, Mr. Michael Overdorf, Executive Vice President and Chief Business Officer, and Dr. Ted Yednock, Executive Vice President and Chief Innovation Officer. Would also like to introduce Katie Wechsler of KPMG, the company's independent registered public accounting firm, and Richard Kim of Latham & Watkins, the company's outside legal counsel, who are joining us online today. We have made available both the agenda of this meeting and certain operating procedures under the materials button on the bottom right-hand side of your computer screen. In order to conduct an orderly meeting, we ask that participants abide by these procedures. We appreciate your cooperation in this matter. The meeting will now officially come to order. We will proceed with the formal business of the meeting as set forth in your notice of annual meeting and proxy statement. After the formal meeting part of the meeting, we will provide time for appropriate questions. Will the secretary please report at this time with respect to the stockholders list and the mailing of the notice of the meeting? I have a complete list of the stockholders of record of the company's common stock, April 14, 2022, the record date for this meeting. This list of stockholders and the number of shares held by each such stockholder as of the record date is available on the web portal for any stockholder wishing to inspect it. An affidavit has been delivered certifying that on or about April 29, 2022, a notice of annual meeting of stockholders of the company was deposited in the United States mail to all stockholders of record at the close of business on April 14, 2022. Thank you. At this time, I'd like to introduce Wendy Shiba of CT Hagberg, who is acting as Inspector of Election at this meeting. Ms. Shiba has taken and subscribed the customary oath of office to execute her duties with strict impartiality. We will file this oath with the records of the meeting. Will the secretary please report at this time with respect to the existence of a quorum? I have been informed by the Inspector of Election that proxies have been received for 34,842,686 shares of the 38,563,565 shares of common stock outstanding on the record date, which represents approximately 90.3% of the total number of outstanding shares. This constitutes a quorum for the meeting today, and we may now carry out the official business of the meeting. Thank you. We'll now proceed with the formal business of this meeting. There are three proposals to be considered by the stockholders at this meeting. The polls open today, Thursday, June 9, 2022 at 9:00 AM Pacific Daylight Time for voting on all matters to be presented. The polls will be closed to voting after we go through the matters to be voted on. The first item of business is the election of two class two Directors to hold office until 2025 Annual Meeting of Shareholders or until their respective successors are duly elected and qualified. The nominees of the two directors are Jung E. Choi and William Waddill. The second item of business is the ratification of the audit committee's election of KPMG as the company's independent registered public accounting firm for the fiscal year ending December 31, 2022. The third item of business is the approval of the frequency of future advisory votes on the compensation of our named executive officers. Stockholders have the option of selecting a frequency of one, two or three years or abstaining. That was the final proposal for today's meeting. Is there any discussion? The secretary will now describe the voting procedures. Stockholders who proxies or voted via telephone or the Internet and do not wish to change their vote, do not need to take any further action. Any stockholder who has not yet voted or wishes to change their vote may do so by clicking on the voting button on the web portal and following the instructions there. Only stockholders of record on April 14, 2022 are eligible to vote at this meeting. We are now going to take a short pause to allow for any stockholders who have not yet voted to do so. The time is now 9:07 AM, and the polls are now closed for voting. Thank you. May we have the preliminary results of the voting? The preliminary report of the Inspector of Election covering the proposals presented at this meeting indicates that number one, proposal to elect Jung E. Choi and William Waddill as Class Two directors of the company is carried. Item two, the selection of KPMG as the company's independent registered public accounting firm for the fiscal year ending December 31, 2025. Number three, one year has been selected as the frequency of future advisory votes on the compensation of our named executive officers. The final voting results will be set forth in the report of the Inspector of Elections, which will be included as part of the record of this meeting. We expect to report our final voting results on a current report on Form 8-K to be filed with the SEC within four business days after the end of this meeting. This concludes the formal portion of today's meeting. Is there any discussion? Is there any opposition to concluding this meeting? This meeting is concluded. This concludes today's meeting. You may now disconnect.